Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980;10(Suppl 2):391S–393S. doi: 10.1111/j.1365-2125.1980.tb01828.x

Abuse and paradoxical effects of analgesic drug mixtures

Roland Wörz
PMCID: PMC1430180  PMID: 7437279

Abstract

1 In patients with chronic pain, two types of analgesic drug dependence occur, that is, dependence of the barbiturate-type and of the morphine-type. Eighty cases of analgesic drug dependence of the barbiturate-type were examined. All these patients were dependent on drug combinations, not a single patient being on one analgesic alone.

2 Psychotropic agents were found to be the common pharmacological denominator of all abused preparations. These findings confirm the hypothesis that the addition of psychotropic or dependence-producing substances to analgesics is the crucial factor in the complex of mild analgesic drug abuse.

3 One group of patients with chronic pain, who were dependent on analgesic drug mixtures, had both lowered experimental pain thresholds and tolerances. After drug withdrawal, these parameters showed a tendency to increase in some patients.

Full text

PDF
391S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNAYS L. Zum Problem der Schmerzmittelsucht. Schweiz Med Wochenschr. 1957 Aug 3;87(31):1022–concl. [PubMed] [Google Scholar]
  2. Eddy N. B., Halbach H., Isbell H., Seevers M. H. Drug dependence: its significance and characteristics. Bull World Health Organ. 1965;32(5):721–733. [PMC free article] [PubMed] [Google Scholar]
  3. FAHRNI R. Intoxikationspsychosen durch Sedormid, Saridon und "Contra-Schmerz". Schweiz Arch Neurol Psychiatr. 1950;65(1-2):62–82. [PubMed] [Google Scholar]
  4. FRIEDMAN A. P., VON STORCH T. J. Ergotamine tolerance in patients with migraine. J Am Med Assoc. 1955 Mar 12;157(11):881–884. doi: 10.1001/jama.1955.02950280005002. [DOI] [PubMed] [Google Scholar]
  5. Hokkanen E., Waltimo O., Kallanranta T. Toxic effects of ergotamine used for migraine. Headache. 1978 May;18(2):95–98. doi: 10.1111/j.1526-4610.1978.hed1802095.x. [DOI] [PubMed] [Google Scholar]
  6. PETERS G. A., HORTON B. T. Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med. 1950 Dec;36(6):972–973. [PubMed] [Google Scholar]
  7. Rowsell A. R., Neylan C., Wilkinson M. Ergotamine induced headaches in migrainous patients. Headache. 1973 Jul;13(2):65–67. doi: 10.1111/j.1526-4610.1973.hed1302065.x. [DOI] [PubMed] [Google Scholar]
  8. Wörz R., Baar H., Draf W., Garcia J., Gerbershagen H. U., Gross D., Magin F., Ritter K., Scheifele J., Scholl W. Kopfschmerz in Abhängigkeit von Analgetika-Mischpräparaten. MMW Munch Med Wochenschr. 1975 Mar 14;117(11):457–462. [PubMed] [Google Scholar]
  9. Wörz R., Gerbershagen H. U. Medikamentöse Fehlbehandlung bei chronischem Schmerz. MMW Munch Med Wochenschr. 1978 Jun 2;120(22):765–766. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES